Estrella Immunopharma, Inc.
ESLA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001844417
No open-market purchases or sales by Estrella Immunopharma, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $4.99M in total; no superinvestor holds it.
Other share classesESLAW
Q3 2025 vs. Q2 2025
How the institutions holding Estrella Immunopharma, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 11 | 13 | +2 |
| Shares | 634.8K | 743.2K | +108.4K (+17.1%) |
| Value | $559.6K | $878.8K | +$319.3K (+57.1%) |
New holders (3)
Institutions that held Estrella Immunopharma, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 10,373 | $12.3K | 0.00% |
| Renaissance Technologies LLC | 10,689 | $12.3K | 0.00% |
| SBI Securities Co., Ltd. | 1 | $1 | 0.00% |
Sold out (1)
Institutions that held Estrella Immunopharma, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| HRT Financial LP | 17,266 | $14.0K |